Acute pancreatitis after embolization of liver tumors: Frequency and associated risk factors

Pancreatology

Volumn 7, Issue 1, 2007, Pages 53-62

  Lopez Benitez R ^a   Radeleff, B A ^a   Barragan Campos H M ^b   Noeldge, G ^a   Grenacher, L ^a   Richter, G M ^a   Sauer, P ^a   Buchler M ^a   Kauffmann, G ^a   Hallscheidt, P J ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Carcinoma, hepatocellular; Chemoembolization, transarterial; Embolization, bland; Hemangioma, liver; Pancreatitis, acute; Radiology, interventional

Indexed keywords

ALKALINE PHOSPHATASE; AMINOTRANSFERASE; AMYLASE; C REACTIVE PROTEIN; CALCIUM ION; CARBOPLATIN; CREATININE; CYTOSTATIC AGENT; DOXORUBICIN; EMBOSPHERE; FOTEMUSTINE; GLUCOSE; IODINATED POPPYSEED OIL; LACTATE DEHYDROGENASE; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG;

ACUTE PANCREATITIS; ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; AMINOTRANSFERASE BLOOD LEVEL; AMYLASE BLOOD LEVEL; ANATOMY; ARTICLE; ARTIFICIAL EMBOLISM; BILE DUCT CARCINOMA; CALCIUM BLOOD LEVEL; CARCINOID; CONTROLLED STUDY; CORRELATION COEFFICIENT; CREATININE BLOOD LEVEL; DISEASE CLASSIFICATION; FEMALE; FISHER EXACT TEST; GLUCOSE BLOOD LEVEL; HEMANGIOENDOTHELIOMA; HEMATOCRIT; HUMAN; ISCHEMIA; LABORATORY TEST; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKOCYTE; LIVER CELL CARCINOMA; LIVER HEMANGIOMA; LIVER METASTASIS; LIVER TUMOR; MAJOR CLINICAL STUDY; MALE; MATERIAL STATE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; STATISTICAL ANALYSIS; TREATMENT OUTCOME; TRIACYLGLYCEROL LIPASE BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL;

EID: 34248163979     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000101878     Document Type: Article

References (39)

1. Liem MS, Poon RT, Lo CM, Tso WK, Fan ST: Outcome of transarterial chemoembolization in patients with inoperable hepatocellular carcinoma eligible for radiofrequency ablation. World J Gastroenterol 2005;11:4465-4471.
2. Martinez-Gonzalez MN, Mondragon-Sanchez R, Mondragon-Sanchez A, Gomez-Gomez E, Garduno-Lopez AL, Bernal-Maldonado R, Onate-Ocana LF, Ruiz-Molina JM: Cavernous hemangioma of the liver and hepatic hemangiomatosis. Indications and results of the surgical resection (in Spanish). Rev Gastroenterol Mex 2003;68:277-282.
3. Llovet JM, Real MI, Montana X, Planas R, Coll S, Aponte J, Ayuso C, Sala M, Muchart J, Sola R, Rodes J, Bruix J: Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 2002;359:1734-1739.
4. Khan KN, Nakata K, Shima M, Kusumoto Y, Ishii N, Koji T, Nagataki S: Pancreatic tissue damage by transcatheter arterial embolization for hepatoma. Dig Dis Sci 1993;38:65-70.
5. Roullet MH, Denys A, Sauvanet A, Farges O, Vilgrain V, Belghiti J: Acute clinical pancreatitis following selective transcatheter arterial chemoembolization of hepatocellular carcinoma (in French). Ann Chir 2002;127:779-782.
6. Bradley EL 3rd: Atlanta redux. Pancreas 2003;26:105-106.
7. Bradley EL 3rd: A clinically based classification system for acute pancreatitis. Ann Chir 1993;47:537-541.
8. Bradley EL 3rd: A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13, 1992. Arch Surg 1993;128:586-590.
9. Pitchumoni CS, Patel NM, Shah P: Factors influencing mortality in acute pancreatitis: can we alter them? J Clin Gastroenterol 2005;39:798-814.
10. Russo MW, Wei JT, Thiny MT, Gangarosa LM, Brown A, Ringel Y, Shaheen NJ, Sandler RS: Digestive and liver diseases statistics, 2004. Gastroenterology 2004;126:1448-1453.
11. Bruix J, Sala M, Llovet JM: Chemoembolization for hepatocellular carcinoma. Gastroenterology 2004;127(suppl 1):S179-S188.
12. Llovet JM, Bruix J: Unresectable hepatocellular carcinoma: meta-analysis of arterial embolization. Radiology 2004;230:300-302.
13. Bruix J, Llovet JM, Castells A, Montana X, Bru C, Ayuso MC, Vilana R, Rodes J: Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution. Hepatology 1998;27:1578-1583.
14. Dervenis CG: Staging acute pancreatitis: where are we now? Pancreatology 2001;1:201-206.
15. Venkatesan T, Moulton JS, Ulrich CD, 2nd, Martin SP: Prevalence and predictors of severity as defined by Atlanta criteria among patients presenting with acute pancreatitis. Pancreas 2003;26:107-110.
16. Stefanini GF, Amorati P, Biselli M, Mucci F, Celi A, Arienti V, Roversi R, Rossi C, Re G, Gasbarrini G: Efficacy of transarterial targeted treatments on survival of patients with hepatocellular carcinoma. An Italian experience. Cancer 1995;75:2427-2434.
17. Leung DA, Goin JE, Sickles C, Raskay BJ, Soulen MC: Determinants of postembolization syndrome after hepatic chemoembolization. J Vasc Interv Radiol 2001;12:321-326.
18. Kolmannskog F, Kolbenstvedt AN, Schrumpf E, Hanssen LE: Side effects and complications after hepatic artery embolization in the carcinoid syndrome. Scand J Gastroenterol 1991;26:557-562.
19. Takeda K, Mikami Y, Fukuyama S, Egawa S, Sunamura M, Ishibashi T, Sato A, Masamune A, Matsuno S: Pancreatic ischemia associated with vasospasm in the early phase of human acute necrotizing pancreatitis. Pancreas 2005;30:40-49.
20. Kishimoto W, Nakao A, Takagi H, Hayakawa T: Acute pancreatitis after transcatheter arterial embolization (TAE) for hepatocellular carcinoma. Am J Gastroenterol 1989;84:1396-1399.
21. Govindan R, Read W, Faust J, Mc Leod H: Irinotecan and carboplatin in metastatic or recurrent non-small-cell lung cancer. Oncology (Williston Park) 2003;17(suppl 7):27-29.
22. Olson EL, Whang YE: Hypertriglyceridemia and pancreatitis associated with estramustine phosphate. Am J Clin Oncol 2002;25:342-343.
23. Wynn D, Everett GD, Boothby RA: Small cell carcinoma of the ovary with hypercalcemia causes severe pancreatitis and altered mental status. Gynecol Oncol 2004;95:716-718.
24. Kumar DM, Sundar S, Vasanthan S: A case of paclitaxel-induced pancreatitis. Clin Oncol (R Coll Radiol) 2003;15:35.
25. Nicoli N, Marchiori L, Mansueto GC, Morana G, Bellini A, Musajo F, Bortolasi L, Dal Dosso I, Costa V, Pederzoli P, et al: Treatment of hepatocellular carcinoma. J Surg Oncol Suppl 1993;3:70-73.
26. Chuang VP, Wallace S, Stroehlein J, Yap HY, Patt YZ: Hepatic artery infusion chemotherapy: gastroduodenal complications. AJR Am J Roentgenol 1981;137:347-350.
27. Ku Y, Fukumoto T, Iwasaki T, Tominaga M, Samizo M, Nishida T, Kuroda Y, Hirota S, Sako M, Obara H, et al: Clinical pilot study on high-dose intraarterial chemotherapy with direct hemoperfusion under hepatic venous isolation in patients with advanced hepatocellular carcinoma. Surgery 1995;117:510-519.
28. Kern W, Beckert B, Lang N, Stemmler J, Beykirch M, Stein J, Goecke E, Waggershauser T, Braess J, Schalhorn A, Hiddemann W: Phase I and pharmacokinetic study of hepatic arterial infusion with oxaliplatin in combination with folinic acid and 5-fluorouracil in patients with hepatic metastases from colorectal cancer. Ann Oncol 2001;12:599-603.
29. Civalleri D, Esposito M, De Caro G, Borgonovo G, De Cian F, Mondini G, Vannozzi O, Bocchio MM, Carrabetta S: Lipiodol with and without Gelfoam in primary liver tumors. Plasma levels of Mitoxantrone and clinical results (in Italian). G Chir 1997;18:362-367.
30. Brown KT, Nevins AB, Getrajdman GI, Brody LA, Kurtz RC, Fong Y, Blumgart LH: Particle embolization for hepatocellular carcinoma. J Vasc Interv Radiol 1998;9:822-828.
31. Maluccio M, Covey AM, Gandhi R, Gonen M, Getrajdman GI, Brody LA, Fong Y, Jarnagin W, D'Angelica M, Blumgart L, DeMatteo R, Brown KT: Comparison of survival rates after bland arterial embolization and ablation versus surgical resection for treating solitary hepatocellular carcinoma up to 7 cm. J Vasc Interv Radiol 2005;16:955-961.
32. Stampfl S, Stampfl U, Rehnitz C, Schnabel P, Satzl S, Christoph P, Henn C, Thomas F, Kauffmann G, Richter GM: Experimental evaluation of early and long term effects of microparticle embolization in two different mini-pig models: Part I: Kidney. Cardiovasc Intervent Radiol 2006, in press.
33. Stampfl S, Stampfl U, Rehnitz C, Schnabel P, Satzl S, Christoph P, Henn C, Thomas F, Kauffmann G, Richter GM: Experimental evaluation of early and long term effects of microparticle embolization in two different mini-pig models: Part II: Liver. Cardiovasc Intervent Radiol 2006, in press.
34. Redha F, Uhlschmid G, Ammann RW, Freiburghaus AU: Injection of microspheres into pancreatic arteries causes acute hemorrhagic pancreatitis in the rat: a new animal model. Pancreas 1990;5:188-193.
35. Goin JE, Salem R, Carr BI, Dancey JE, Soulen MC, Geschwind JF, Goin K, Van Buskirk M, Thurston K: Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: a risk-stratification analysis. J Vasc Interv Radiol 2005;16:195-203.
36. Geschwind JF, Salem R, Carr BI, Soulen MC, Thurston KG, Goin KA, Van Buskirk M, Roberts CA, Goin JE: Yttrium-90 microspheres for the treatment of hepatocellular carcinoma. Gastroenterology 2004;127(suppl 1):S194-S205.
37. Mayerle J, Hlouschek V, Lerch MM: Current management of acute pancreatitis. Nat Clin Pract Gastroenterol Hepatol 2005;2:473-483.
38. Marchiori L, Mansueto GC, Nifosi F, Bortolasi L, Dal Dosso I, Facci E, Perus G, Nicoli N: The treatment of hepatocellular carcinoma by chemoembolization (in Italian). Chir Ital 1994;46:17-22.
39. Demircan O, Demiryurek H, Yagmur O: Surgical approach to symptomatic giant cavernous hemangioma of the liver. Hepatogastroenterology 2005;52:183-186.